Fibrosis meeting, Bergen 2022

Symposium on tumor and tissue fibrosis

Group picture of Fibrosis Meeting in Bergen 2022

Foto/ill.:

Torstein Ravnskog/UiB

Hovedinnhold

Oppdatert: 01.07.2022 (Først publisert: 15.06.2022)

Symposium on tumor and tissue fibrosis

Bergen, Norway

Venue: June 9-10, 2022 - Max 60 attendants (including speakers) at Hotel Terminus.
There will also be a live streaming of the event on Zoom.

Organizer: Donald Gullberg
All the sessions will be in-person, but also streamed live as Zoom webinar, and will be recorded and placed on a private YouTube channel. A link to the videos on YouTube will be sent to all the participants of the symposium.

Thursday June 9
Local time Bergen, Norway (CEST^*, UTC+2)	Speakers Title
9.00 - 9.40	Donald Gullberg, University of Bergen What is a fibroblast?
9.50 -10.30	Ritva Heljasvaara, University of Oulu Collagens XIII and XV in fibrosis
10.40-11.00	Coffee
11.00-11.40	Sergey Plotnikov, UoT, Canada Cytoskeleton protection by formin mDia1 is essential for cell responses to profibrotic stimuli
11.50-13.00	Lunch
13.50-14.30	Roger Oria-Fernandez, UCSF Mechanotransduction in cancer
14.40-15.20	Chris McCulloch, UoT, Canada Role of DDR1 in fibrosis
15.40-16.00	Coffee
16.10-16.50	Tom Barker, University of Virginia The Matrix: a major driver and therapeutic target of Fibrosis
17.00-17.40	Andreas Romaine, UiO, Norway Heart fibrosis
19.00	Conference Dinner
Friday June 10
9.00 - 9.40	Ronen Schuster, CytoReason, Tel Aviv High content approach to map fibroblast-macrophage interactions
9.50-10.30	Andrew Leask, USask, Canada Turning it up to Eleven: Targeting the microenvironment in fibrotic condition
10.40-11.00	Coffee
11.00-11.40	Daniela Costea, University of Bergen CAF heterogeneity in squamous cell carcinoma
11.50-12.30	Daniela Costea, Harsh Dongre and Stian Tornaas, University of Bergen Hyperion demonstration
12.40-13.20	Coffee
13.20-14.00	Roya Navab, University of Toronto CAF heterogeneity in drug-tolerant persister non-small cell lung cancer tumor
14.10-14.50	Humphrey Gardner, Roivant Sciences, Boston Stromal phenotypic markers and disease outcome in solid tumors
15.00-15.40	Erine Budi, Pliant Therapeutics, San Francisco Development of Integrin Inhibitors to Treat Fibrotic Disease
15.50-16.00	Coffee

^{*) CEST = Central European Summer Time}

Speakers

Donald Gullberg
Ritva Heljasvaara
Sergey Plotnikov
Roger Oria-Fernandez
Chris McCulloch
Tom Barker
Andreas Romaine
Ronen Schuster
Andrew Leask
Daniela E. Costea
Harsh Dongre
Stian Tornaas
Roya Navab
Humphrey Gardner
Erine Budi